GDRX
Income statement / Annual
Last year (2025), GoodRx Holdings Inc's total revenue was $796.85 M,
an increase of 0.57% from the previous year.
In 2025, GoodRx Holdings Inc's net income was $30.44 M.
See GoodRx Holdings Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$796.85 M |
$792.32 M |
$750.27 M |
$766.55 M |
$745.42 M |
$550.70 M |
$388.22 M |
$249.52 M |
$157.24 M |
$99.38 M |
| Cost of Revenue |
$57.60 M
|
$48.22 M
|
$66.93 M
|
$65.08 M
|
$46.72 M
|
$29.59 M
|
$14.02 M
|
$6.04 M
|
$12.17 M
|
$10.32 M
|
| Gross Profit |
$739.26 M
|
$744.11 M
|
$683.34 M
|
$701.48 M
|
$698.71 M
|
$521.11 M
|
$374.21 M
|
$243.49 M
|
$145.07 M
|
$89.06 M
|
| Gross Profit Ratio |
0.93
|
0.94
|
0.91
|
0.92
|
0.94
|
0.95
|
0.96
|
0.98
|
0.92
|
0.9
|
| Research and Development Expenses |
$121.03 M
|
$123.75 M
|
$135.84 M
|
$143.14 M
|
$125.86 M
|
$61.82 M
|
$29.30 M
|
$43.89 M
|
$11.50 M
|
$5.74 M
|
| General & Administrative Expenses |
$113.96 M
|
$117.86 M
|
$125.52 M
|
$144.79 M
|
$154.69 M
|
$461.45 M
|
$14.69 M
|
$8.36 M
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$331.56 M
|
$367.11 M
|
$341.33 M
|
$357.63 M
|
$370.22 M
|
$255.14 M
|
$176.97 M
|
$104.18 M
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$445.52 M
|
$484.98 M
|
$466.84 M
|
$502.42 M
|
$524.90 M
|
$716.59 M
|
$191.66 M
|
$112.54 M
|
$83.26 M
|
$64.40 M
|
| Other Expenses |
$85.22 M
|
$69.54 M
|
$107.67 M
|
$54.18 M
|
$34.54 M
|
$18.43 M
|
$13.57 M
|
-$7.00 K
|
$0.00
|
$0.00
|
| Operating Expenses |
$651.76 M
|
$678.26 M
|
$710.35 M
|
$699.74 M
|
$685.30 M
|
$796.83 M
|
$234.53 M
|
$166.24 M
|
$94.76 M
|
$70.14 M
|
| Cost And Expenses |
$709.36 M
|
$726.48 M
|
$777.27 M
|
$764.82 M
|
$732.02 M
|
$826.42 M
|
$248.55 M
|
$172.27 M
|
$106.93 M
|
$80.46 M
|
| Interest Income |
$10.93 M
|
$23.27 M
|
$32.17 M
|
$9.27 M
|
$59.00 K
|
$160.00 K
|
$715.00 K
|
$154.00 K
|
$24.00 K
|
$21.00 K
|
| Interest Expense |
$42.61 M
|
$52.92 M
|
$56.73 M
|
$34.24 M
|
$23.64 M
|
$27.91 M
|
$49.57 M
|
$22.19 M
|
$6.97 M
|
$3.54 M
|
| Depreciation & Amortization |
$85.22 M
|
$69.54 M
|
$107.67 M
|
$54.18 M
|
$34.54 M
|
$18.43 M
|
$13.57 M
|
$9.81 M
|
$9.10 M
|
$9.09 M
|
| EBITDA |
$184.36 M |
$153.92 M |
$108.82 M |
$65.19 M |
$48.00 M |
-$257.11 M |
$146.12 M |
$84.35 M |
$59.41 M |
$28.01 M |
| EBITDA Ratio |
0.23
|
0.19
|
0.15
|
0.09
|
0.06
|
-0.47
|
0.38
|
0.34
|
0.38
|
0.28
|
| Operating Income Ratio |
0.11
|
0.08
|
-0.04
|
0
|
0.02
|
-0.5
|
0.36
|
0.31
|
0.32
|
0.19
|
| Total Other Income/Expenses Net |
-$30.95 M
|
-$34.39 M
|
-$28.57 M
|
-$24.97 M
|
-$23.58 M
|
-$27.73 M
|
-$56.70 M
|
-$24.90 M
|
-$10.60 M
|
-$3.82 M
|
| Income Before Tax |
$56.54 M
|
$31.46 M
|
-$55.57 M
|
-$23.23 M
|
-$10.18 M
|
-$303.45 M
|
$82.98 M
|
$52.35 M
|
$39.70 M
|
$15.10 M
|
| Income Before Tax Ratio |
0.07
|
0.04
|
-0.07
|
-0.03
|
-0.01
|
-0.55
|
0.21
|
0.21
|
0.25
|
0.15
|
| Income Tax Expense |
$26.10 M
|
$15.07 M
|
-$46.70 M
|
$9.60 M
|
$15.08 M
|
-$9.83 M
|
$16.93 M
|
$8.56 M
|
$10.93 M
|
$6.19 M
|
| Net Income |
$30.44 M
|
$16.39 M
|
-$8.87 M
|
-$32.83 M
|
-$25.25 M
|
-$293.62 M
|
$66.05 M
|
$43.79 M
|
$8.84 M
|
-$7.77 M
|
| Net Income Ratio |
0.04
|
0.02
|
-0.01
|
-0.04
|
-0.03
|
-0.53
|
0.17
|
0.18
|
0.06
|
-0.08
|
| EPS |
0.0854 |
0.0425 |
-0.0216 |
-0.08 |
-0.06 |
-1.07 |
0.12 |
0.12 |
0.0229 |
-0.0202 |
| EPS Diluted |
0.0853 |
0.0418 |
-0.0216 |
-0.08 |
-0.06 |
-1.07 |
0.12 |
0.12 |
0.0229 |
-0.0202 |
| Weighted Average Shares Out |
$356.33 M
|
$385.74 M
|
$410.32 M
|
$412.86 M
|
$409.98 M
|
$274.70 M
|
$356.07 M
|
$356.07 M
|
$385.38 M
|
$385.38 M
|
| Weighted Average Shares Out Diluted |
$356.97 M
|
$392.17 M
|
$410.32 M
|
$412.86 M
|
$409.98 M
|
$274.70 M
|
$362.60 M
|
$362.60 M
|
$385.38 M
|
$385.38 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
